| Literature DB >> 26084041 |
Hong Kim1, Bum-Joon Kim2.
Abstract
Occult hepatitis B virus infection (HBV) is characterized by HBV DNA positivity but HBV surface antigen (HBsAg) negativity. Occult HBV infection is associated with a risk of HBV transmission through blood transfusion, hemodialysis, and liver transplantation. Furthermore, occult HBV infection contributes to the development of cirrhosis and hepatocellular carcinoma. We recently reported the characteristic molecular features of mutations in the preS/S regions among Korean individuals with occult infections caused by HBV genotype C2; the variants of preS and S related to severe liver diseases among chronically infected patients were also responsible for the majority of HBV occult infections. We also reported that HBsAg variants from occult-infected Korean individuals exhibit lower HBsAg secretion capacity but not reduced HBV DNA levels. In addition, these variants exhibit increased ROS-inducing capacity compared with the wild-type strain, linking HBV occult infections to liver cell damage. Taken together, our previous reports suggest the transmission potential of distinct HBV occult infection-related variants in South Korea.Entities:
Keywords: HBV surface antigen (HBsAg); South Korea; genotype C2; hepatitis B virus infection (HBV); occult infection; preS/S mutations
Mesh:
Substances:
Year: 2015 PMID: 26084041 PMCID: PMC4490511 DOI: 10.3390/ijms160613595
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Prevalence of occult HBV infection from in Korean subjects, and the distribution of serotype and HBeAg serostatus of occult subjects.
| No. of HBsAg (−) Subjects | No. of Subjects Positive for Nested PCR | Prevalence | ||
|---|---|---|---|---|
| 624 | 41 | 6.6% | ||
| Untypeable | ||||
| 39 (95.2%) | 1 (2.4%) | 1 (2.4%) | ||
| 15 (71.4%) | ||||
a All forty-one subjects with occult HBV infections were proved to have genotype C2 infections; b HBeAg serological analysis was performed for 21 of 41 subjects for whom serum samples were available.
PreS/S mutations related to occult infections in South Korea.
| Regions | Types | Polymerase | Occult ( | Carriers ( | Clinical Relevance | |
|---|---|---|---|---|---|---|
| Hepatocyte receptor binding region | - | 29 (70.7%) | 7 (17.5%) | <0.001 | [ | |
| Start codon deletion | spacer6-12 Deletion | 11 (26.8%) | 3 (7.5%) | <0.05 | [ | |
| W4P/R | spacerL9D | 7 (17.1%) | 2 (5.0%) | 0.087 | [ | |
| K/Q10R | - | 6 (14.6%) | 0 (0%) | <0.05 | - | |
| S17A | spacerF22C | 5 (12.2%) | 0 (0%) | <0.05 | - | |
| P32L | - | 5 (12.2%) | 0 (0%) | <0.05 | - | |
| W43L/R | spacerL48S | 6 (14.6%) | 0 (0%) | <0.05 | - | |
| H51P | - | 5 (12.2%) | 1 (2.5%) | 0.096 | - | |
| I84T | - | 7 (17.1%) | 0 (0%) | <0.01 | - | |
| Deletion | spacer132-147 Deletion | 7 (17.1%) | 1 (2.5%) | <0.05 | [ | |
| M1L/T/V | - | 4 (9.8%) | 1 (2.5%) | 0.175 | - | |
| W3R/* | - | 6 (14.6%) | 0 (0%) | <0.05 | - | |
| S5A | - | 5 (12.2%) | 0 (0%) | <0.05 | - | |
| “a” determinant | - | 31 (75.6%) | 5 (12.5%) | <0.001 | - | |
| I/T126N/S | - | 11 (26.8%) | 3 (7.5%) | <0.05 | - | |
| W182L/* | - | 15 | 0 (0%) | <0.001 | [ |
Figure 1Transmission potential of distinct HBV occult infection-related variants in South Korea.